The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway (Q40858871)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2000
edit
Language Label Description Also known as
English
The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway
scientific article published on September 2000

    Statements

    The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway (English)
    1 reference
    K U Birkenkamp
    1 reference
    L M Tuyt
    1 reference
    C Lummen
    1 reference
    A T Wierenga
    1 reference
    W Kruijer
    1 reference
    E Vellenga
    1 reference
    1 September 2000
    1 reference
    131
    1 reference
    1
    1 reference
    99-107
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit